InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,660.00
(
0.33%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.10
(
0.17%
)
Bitcoin
62,888.67
(
-0.25%
)
Post# of 1990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

michaeldesanta

Send PM Follow Ignore
Followers 15
Posts 308
Boards Moderated 0
Alias Born 03/25/2014

michaeldesanta

Re: None

Wednesday, 09/20/2017 11:16:29 AM

Wednesday, September 20, 2017 11:16:29 AM

Post# of 1990
$ARGS The ESMO presentation went well and the study suggests survivability with MRCC. I anticipate this is what Dr. Figlin is going to cover.

https://www.esmo.org/Conferences/ESMO-2017-Congress/News-Articles/Rocapuldencel-T-Shows-Potential-Benefit-in-Metastatic-Renal-Cell-Carcinoma
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up